UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934

Date of Report (Date of earliest event reported): ~~May~~July 511, 2025

HEARTBEAM, INC.

(Exact name of Registrant as specified in its charter)

Delaware		001-41060		47-4881450
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)

2118 Walsh Avenue, Suite 210

Santa Clara, CA 95050

(Address of principal executive offices, including zip code)

(408) 899-4443

(Registrant’s telephone number, including area code)

Check the appropriate box below if the 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:

☐	Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)).

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock	BEAT	NASDAQ
Warrant	BEATW	NASDAQ

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ ☒

Item 5.0207 ~~Departure~~Submission of ~~Directors~~Matters orto ~~Certain~~a ~~Officers;~~Vote ~~Election~~ of ~~Directors;~~Security ~~Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.~~Holders

~~Appointment~~On July 11, 2025, HeartBeam, Inc. (the “Company”) held an annual meeting of ~~Board~~stockholders ~~Member~~(the “Annual Meeting”) virtually, via live webcast.

OnAs of the close of business on May 512, 2025, the record ~~Board~~date offor ~~Directors~~the Annual Meeting (the “~~Board~~Record Date”), 33,809,707 shares of ~~HeartBeam~~the Company’s common stock, ~~Inc.~~par value $0.0001 (the “~~Company~~Common Stock”) ~~appointed~~ ~~Robert~~were ~~Eno~~outstanding and entitled to vote. At the Annual Meeting, a total of 18,702,366 votes, comprised of shares of the Company’s ~~Chief~~Common ~~Executive Officer~~Stock, asequivalent ato ~~member~~approximately 55.32% of the ~~Board~~outstanding ~~effective~~votes, aswere ofrepresented ~~May~~in 5,person or ~~2025~~by (proxy at the ~~“Director Appointment”)~~Annual Meeting, constituting a quorum. InThe ~~connection~~matters ~~with~~that were voted upon at the ~~Director~~Annual ~~Appointment~~Meeting, and the ~~Board~~number ~~elected~~of tovotes cast ~~expand~~for ~~from~~or ~~eight~~against/withheld, toas ~~nine~~well ~~members~~as the number of abstentions and broker non-votes, as to ~~accommodate~~such matters, where applicable, are set ~~this~~forth ~~addition~~below.

~~Family~~1. ~~Relationships~~The nine nominees for director were elected to serve a one-year term as follows:

Mr. Eno does not have a family relationship with any of the current officers or directors of the Company.

Director	Votes For	Votes Against	Abstain	Broker Non-Vote
Richard Ferrari	6,796,276	237,566	88,764	11,579,760
Branislav Vajdic, PhD	6,971,395	64,960	86,251	11,579,760
George A. de Urioste	6,748,429	165,710	208,467	11,579,760
Marga Ortigas-Wedekind	5,153,730	1,878,916	89,960	11,579,760
Willem Elfrink	6,867,987	162,120	92,499	11,579,760
Mark Strome	5,499,488	1,531,719	91,399	11,579,760
Kenneth Nelson	6,996,326	36,889	89,391	11,579,760
Michael Jaff	6,992,884	37,023	92,699	11,579,760
Robert Eno	6,995,306	41,109	86,191	11,579,760

~~Related~~2. ~~Party~~The ~~Transactions~~proposal to ratify the appointment of CBIZ CPAs P.C. as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2025, was approved as follows:

There are no related party transactions with regard to Mr. Eno reportable under Item 404(a) of Regulation S-K.

Votes For			Votes Against			Broker Non-Votes			Votes Abstained
18,388,997			55,859			0			257,510

~~Item 7~~3.01 ~~Regulation~~The FDproposal ~~Disclosure.~~to amend the 2022 Equity Incentive Plan to increase the number of authorized shares from 8,900,000 shares to 11,900,000 shares:

On May 5, 2025, the Company issued a press release announcing the Director Appointment. A copy of the press release is filed hereto as Exhibit 99.1 and is incorporated herein by reference.

Votes For			Votes Against			Broker Non-Votes			Votes Abstained
4,375,827			2,717,474			11,579,760			29,305

~~The information set forth under this~~ Item 79.01 isFinancial ~~furnished~~Statements ~~pursuant to Item 7.01~~ and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall it be incorporated by reference into any registration document or other document filed by the Company.Exhibits

~~Item~~(d) ~~9.01 Financial Statements and~~ Exhibits.

(d) Exhibits

Exhibit Number		Description
10.1		Third Amendment to the HeartBeam, Inc. 2022 Equity Incentive Plan
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

Exhibit Number		Description
99.1		Press Release dated May 5, 2025
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

1SIGNATURES

~~SIGNATURES~~Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

	HeartBeam, Inc.

Date: July 16, 2025		/s/ Timothy Cruickshank
	Name:	Timothy Cruickshank
	Title:	Chief Financial Officer

	HeartBeam, Inc.
Date: May 5, 2025	By:	/s/ Timothy Cruickshank
	Name:	Timothy Cruickshank
	Title:	Chief Financial Officer

Filing Compare · HeartBeam, Inc.